Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status

Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status

Tofacitinib is an oral, small-molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We summarize the efficacy and safety data of tofacitinib 5 or 10 mg twice daily in the UC clinical program, stratified by prior tumor necrosis factor inhibitor (TNFi) failure status.Efficacy w...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: William J. Sandborn, Laurent Peyrin–Biroulet, Ala I. Sharara, Chinyu Su, Irene Modesto, Rajiv Mundayat, Levent Mert Günay, Leonardo Salese, Bruce E. Sands
Formáid: Artigo
Teanga:Béarla
Foilsithe / Cruthaithe: 2021
Rochtain ar líne:https://doi.org/10.1016/j.cgh.2021.02.043
http://www.cghjournal.org/article/S1542356521002226/pdf
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Ar líne

https://doi.org/10.1016/j.cgh.2021.02.043
http://www.cghjournal.org/article/S1542356521002226/pdf

Míreanna comhchosúla